Full history for every metric is available with a Kvantra account
Monogram Orthopaedics, Inc. (MGRM)
Key financial summary
Financials in USD| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | TTM | ||
|---|---|---|---|---|---|---|---|---|
| Total revenue | $m | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
| Operating profit | $m | -15 | -14 | |||||
| Net profit | $m | -2 | -9 | -12 | -14 | -14 | -16 | -18 |
| EPS reported | $ | -0.50 | -0.55 | |||||
| Operating cashflow per share | $ | -0.43 | 0.00 | |||||
| Capex per share | $ | 0.00 | 0.00 | |||||
| FCF per share | $ | -0.43 | 0.00 | |||||
| Free cash flow | $m | -14 | -8 | |||||
| Net debt | $m | -16 | -13 | |||||
| Book value equity | $m | 15 | 9 | |||||
| Book value per share | $ | 0.45 | 0.24 | |||||
| Number of shares | m | 32.57 | 35.51 | |||||
| DPS (TTM paid) | $ | 0.00 | 0.00 |
Financial summary
Financials in USD| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | TTM | ||
|---|---|---|---|---|---|---|---|---|
| Value | ||||||||
| P/E TTM | x | - | - | |||||
| P/B LTM | x | 5.32 | 28.29 | |||||
| P/S LTM | x | 0.00 | 572.98 | |||||
| P/FCF LTM | x | -5.49 | -32.24 | |||||
| EV/EBITDA LTM | x | -3.89 | -14.12 | |||||
| EV/Sales LTM | x | 0.00 | 543.17 | |||||
| Earnings Yield LTM | % | -21.15% | -4.05% | |||||
| FCF Yield | % | -18.20% | -3.10% | |||||
| Quality | ||||||||
| ROE | % | -112.58% | -85.00% | |||||
| ROIC | % | -93.54% | -71.86% | |||||
| Operating margin | % | 0.00% | 0.00% | |||||
| Gross margin | % | 0.00% | 0.00% | |||||
| FCF/Sales | % | - | - | |||||
| Growth and momentum | ||||||||
| EPS Growth YoY | % | - | - | |||||
| Sales Growth YoY | % | -100.00% | +16.57% | |||||
| Net Income Growth YoY | % | - | - | |||||
| FCF Growth | % | - | - | |||||
| Operating Profit Growth | % | - | - | |||||
| Dividend and capital structure | ||||||||
| Dividend Yield | % | 0.00% | 0.00% | |||||
| Dividend Growth | % | 0.00% | 0.00% | |||||
| Payout Ratio | % | 0.00% | -1.31% | |||||
| FCF/Debt | x | -38.60 | -16.84 | |||||
| Net Debt/EBITDA | x | 0.96 | 1.45 | |||||
| EBIT/Net interest | x | 0.00 | 0.00 | |||||
| Net debt/market cap | % | -20.28% | -5.20% | |||||
| Net debt/Equity | x | -1.08 | -1.47 | |||||
| Gross debt/equity | x | 0.03 | 0.05 | |||||
Company overview
Monogram Orthopaedics, Inc. (MGRM) specializes in developing technologies that enable the mass personalization and optimization of orthopedic implants. The company's strategy involves producing and marketing a comprehensive array of tools for reconstructive joint replacement surgeries, including advanced robotic surgical equipment with integrated software, specialized orthopedic implants, tissue ablation instruments, navigation consumables, and other related surgical accessories. Demonstrating its capabilities, a prototype robot precisely places optimized implants into synthetic bone specimens by executing carefully planned surgical pathways. The company was founded in 2016 and was initially known as Monogram Arthroplasty Inc. before officially rebranding to Monogram Orthopaedics, Inc. in March 2017. Its corporate headquarters are located in Austin, Texas.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
Monogram Orthopaedics, Inc. (MGRM)
Monogram Orthopaedics, Inc. (MGRM) specializes in developing technologies that enable the mass personalization and optimization of orthopedic implants. The company's strategy involves producing and marketing a comprehensive array of tools for reconstructive joint replacement surgeries, including advanced robotic surgical equipment with integrated software, specialized orthopedic implants, tissue ablation instruments, navigation consumables, and other related surgical accessories. Demonstrating its capabilities, a prototype robot precisely places optimized implants into synthetic bone specimens by executing carefully planned surgical pathways. The company was founded in 2016 and was initially known as Monogram Arthroplasty Inc. before officially rebranding to Monogram Orthopaedics, Inc. in March 2017. Its corporate headquarters are located in Austin, Texas.
Unlock all fundamental data
Sign up for FreeUnlock all fundamental data
Sign up for Free